Detalhe da pesquisa
1.
Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
World J Urol
; 41(4): 929-940, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362747
2.
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice.
Eur Urol Open Sci
; 62: 54-60, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585205
3.
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Urol Oncol
; 42(5): 163.e1-163.e13, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443238
4.
Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review.
Eur Urol Open Sci
; 52: 7-21, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182118
5.
PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature.
J Clin Med
; 11(7)2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35407435
6.
Expanding the Role of Ultrasound for the Characterization of Renal Masses.
J Clin Med
; 11(4)2022 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35207384
7.
Hot topics in renal cancer pathology: implications for clinical management.
Expert Rev Anticancer Ther
; 22(12): 1275-1287, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36377655
8.
Thermal ablation for T1b renal cancer: an "I wish I could, but I cannot?"
Minerva Urol Nephrol
; 76(2): 254-259, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742559
9.
Management of de-novo graft masses in kidney transplantation recipients: focusing on available data and unmet clinical needs.
Minerva Urol Nephrol
; 75(2): 242-245, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999839
10.
Selecting the best candidates for non-surgical management of localized renal masses: the Occam's razor.
Minerva Urol Nephrol
; 74(3): 368-371, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607785
11.
Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us?
Minerva Urol Nephrol
; 74(3): 372-375, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607786
12.
Oncological safety of partial nephrectomy for pT3a renal cell carcinoma: reading between the lines.
Minerva Urol Nephrol
; 74(4): 488-491, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848343
13.
Renal surgery in elderly: not all partial nephrectomies should be treated equally.
Minerva Urol Nephrol
; 74(4): 492-496, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848344
14.
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
Eur Urol Open Sci
; 46: 39-42, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325369
15.
Cryoablation of small renal masses in patients with solitary kidneys: worth crossing the road for?
Minerva Urol Nephrol
; 74(6): 794-798, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629808
16.
Optimizing postoperative follow-up in RCC patients: why does it always have to be black and white?
Minerva Urol Nephrol
; 74(6): 822-824, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629817
17.
The impact of ischemic injury in patients with solitary kidneys: new cornerstones for contemporary "precision" robot-assisted partial nephrectomy.
Minerva Urol Nephrol
; 73(6): 851-853, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144369
18.
Inferior vena cava involvement in renal cell carcinoma: if you fail to plan, you're planning to fail.
Minerva Urol Nephrol
; 73(6): 854-857, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144370
19.
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.
Neoplasia
; 16(3): 221-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726142
20.
Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma.
Immunotherapy
; 5(5): 489-95, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23638744